Looking at continued growth across key markets in FY20: Cipla

For the US market, where the company has seen significant growth driven by ramp-up across key differentiated products in FY19, it is looking to scale-up last fiscal’s launches and also introduce more products in FY20 while continuing the specialty investments.

Original source: https://health.economictimes.indiatimes.com/news/pharma/looking-at-continued-growth-across-key-markets-in-fy20-cipla/69507937?utm_source=RSS&utm_medium=ETRSS

Related Posts